欧州における分子診断市場

Abstract

This Frost & Sullivan research service titled European Molecular Diagnostics Markets provides an overview of the molecular diagnostics markets, along with revenues in each market segment.

This study also provides a complete analysis of key market drivers, restraints, and trends. Finally, it provides strategic solutions to the vendors to gain a competitive advantage in the growing markets.

Market Overview

Advances in Automated Diagnostics Solutions to Improve Adaptability of Molecular Tests by Clinical Laboratories

The need for early diagnosis of diseases and improved therapeutic treatment is driving the adoption of molecular diagnostics tests in Europe. Automated and integrated molecular diagnostic solutions have improved assay performance by decreasing the complexities involved in molecular tests. Although these solutions involve a slightly higher cost, the inherent benefits, such as reduced labour and lower cost per assay are promoting their uptake. With continued technological advances and expanding applications, molecular diagnostics is one of the fastest growing areas in the European in-vitro diagnostics (IVD) market.

"Early diagnosis and technological superiority over immunoassays are the key factors driving widespread adoption of molecular tests in Europe," notes the analyst of this research service. "Growing emphasis on improved patient care, better therapeutic options and population screening programs are boosting the adoption of molecular diagnostic tests." Despite the lucrative potential of the market, low awareness levels and high market entry barriers that restrict the development of novel diagnostic products and technologies are factors adversely affecting market growth.

Market Success to Rely on Promoting Awareness of Benefits of Molecular Diagnostic Tests

"Several molecular diagnostic assays are novel in the information they provide to the physician and the patient," states the analyst. "Hence, creating awareness and educating healthcare providers, as well as patients will become essential for the success of the assay and its subsequent reimbursement. "In addition, with technological innovations likely to penetrate the market, IVD manufacturers will need to communicate the value of their technologies to healthcare regulators, payers, providers and patients in order to improve acceptance of molecular diagnostics. Since recommendations by physician and cancer association groups have a powerful influence on the adoption of molecular tests, conducting 'physician awareness programs' will assist in promoting a keen understanding of the latest developments in pharmacogenomics, cancer diagnosis and screening of infectious diseases.

Overall, the uptake of molecular diagnostic tests is gaining momentum as a result of the high revenue potential in the infectious disease diagnostics market. Due to the presence of multinational companies and their dominance, the infectious disease diagnostics market is expected to offer limited opportunities to new entrants. Hence, IVD manufacturers would do well to be aware of the trends in the cancer diagnostics and pharmacogenomic tests segments, which are currently in their growth phase and offer enormous scope for market expansion. Given the positive outlook for the market, revenues are projected to grow from $517.5 million in 2005 to reach $987.5 million by 2012.

Table of Contents

1. Executive Summary

• 1. Summary of the European Molecular Diagnostics Market
  • 1. Overview of European Molecular Diagnostics Market

2. Glossary of Terms and Exchange Rates

• 1. Glossary of Terms and Exchange Rates for the European Molecular Diagnostics Market
  • 1. Glossary of Terms and Scientific Abbreviations
  • 2. Exchange Rates

3. Industry Challenges

• 1. Key Industry Challenges
  • 1. Identification of Challenges Facing the European Molecular Diagnostics Market

4. Market Engineering Research for the Total European Molecular Diagnostics Market

• 1. Forecasts for the European Molecular Diagnostics Market
  • 1. Market Overview
  • 2. Market Segmentation
  • 3. Market Engineering Measurements
  • 4. Market Drivers
  • 5. Market Restraints
  • 6. Revenue Forecasts
  • 7. Market Trends by Geographic Region
  • 8. Technology Trends in the Market
  • 9. End-user Types
  • 10. Competitive Structure
  • 11. Market Share Analysis

5. Market Engineering Research for the Western Europe Molecular Diagnostics Market

• 1. Market Overview
  • 1. Overview of the Western Europe Molecular Diagnostics Market
• 2. Market Engineering Research for the German Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 3. Market Engineering Research for the French Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 4. Market Engineering Research for the Italian Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 5. Market Engineering Research for the Spanish Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 6. Market Engineering Research for the UK Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 7. Market Engineering Research for the Benelux Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 8. Market Engineering Research for the Scandinavian Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 9. Competitive Landscape
  • 1. Competitive Structure

6. Market Engineering Research for the Eastern Europe Molecular Diagnostics Market

• 1. Market Overview
  • 1. Overview of the Eastern Europe Molecular Diagnostics Market
• 2. Market Engineering Research for the Russian Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 3. Market Engineering Research for the Turkish Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 4. Market Engineering Research for the Polish Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 5. Market Engineering Research for the Hungarian Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 6. Market Engineering Research for the Czech Republican Molecular Diagnostics Market
  • 1. Market Engineering Measurements
  • 2. Revenue Forecasts
• 7. Competitive Landscape
  • 1. Competitive Structure

7. Market Engineering Strategic Recommendations

• 1. Strategic Recommendations
  • 1. Strategic Recommendations for the European Molecular Diagnostics Market

8. Frost & Sullivan Awards for the European Molecular Diagnostics Market

• 1. Frost & Sullivan Awards
  • 1. Introduction
  • 2. Product Line Strategy Leadership Award
  • 3. Product Innovation Award

9. Database of Key Industry Participants

• 1. Key Industry Participants
  • 1. Key Industry Participants in the Market

10. Decision Support Databases

• 1. Decision Support Databases
  • 1. Total Healthcare Expenditure
  • 2. Population Above 65
  • 3. AIDS Incidence
  • 4. Cancer Incidence
  • 5. Gonnococcal Infection
  • 6. Hepatitis A Incidence
  • 7. Hepatitis B Incidence
  • 8. Syphilis Cases

List of Figures

Chapter 2

• Total Molecular Diagnostics Market: Exchange Rates (Europe), 2006

Chapter 3

• Molecular Diagnostics Market: Impact of Top Industry Challenges (Europe), 2006-2012

Chapter 4

• Molecular Diagnostics Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2012
• Molecular Diagnostics Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2012
• Molecular Diagnostics Market: Revenue Forecasts (Europe), 2002-2012
• Infectious Diseases Market: Revenue Forecasts (Europe), 2002-2012
• Cancer Diagnostics Market: Revenue Forecasts (Europe), 2002-2012
• Pharmacogenomics Market: Revenue Forecasts (Europe), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Europe), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Geographic Region (Europe), 2002-2012
• Infectious Diseases Market: Per Cent of Revenues by Geographic Region (Europe), 2002-2012
• Cancer Diagnostics Market: Per Cent of Revenues by Geographic Region (Europe), 2002-2012
• Pharmacogenomics Market: Per Cent of Revenues by Geographic Region (Europe), 2002-2012
• Molecular Diagnostics Market: Technology Trends (Europe), 2006-2012
• Molecular Diagnostics Market: Competitive Structure (Europe), 2005
• Molecular Diagnostics Market: Market Share Trends of Major Participants (Europe), 2005

Chapter 5

• Molecular Diagnostics Market: Revenue Forecasts (Germany), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Germany), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (France), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (France), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Italy), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Italy), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Spain), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Spain), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (United Kingdom), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (United Kingdom), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Benelux), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Benelux), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Scandinavia), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Scandinavia), 2002-2012

Chapter 6

• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Russia), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Turkey), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Turkey), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Poland), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Poland), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Hungary), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Hungary), 2002-2012
• Molecular Diagnostics Market: Revenue Forecasts (Czech Republic), 2002-2012
• Molecular Diagnostics Market: Per Cent of Revenues by Segment (Czech Republic), 2002-2012

Chapter 7

• Molecular Diagnostics Market: Strategic Recommendations (Europe), 2006-2012

Chapter 10

• Decision Support Database: Total Healthcare Expenditure in Bn USD (Europe), 2002-2012
• Decision Support Database: Population 65 Plus in Mn (Europe), 2002-2012
• Decision Support Database: AIDS Reported Cases (Europe), 1999-2006
• Decision Support Database: Incidence of Cancer in '000 (Europe), 1999-2006
• Decision Support Database: Gonococcal Infection Cases (Europe), 1999-2006
• Decision Support Database: Incidence of Hepatitis A (Europe), 1999-2006
• Decision Support Database: Incidence of Hepatitis B (Europe), 1999-2006
• Decision Support Database: Number of Syphilis Cases (Europe), 1999-2006